TMPRSS2–ERG fusion accounted for 40–50% of the patients diagnosed with PCa, while TMPRSS2 fused to ETV4, ETV5 and ETV1 has also contributed to 1–5% of PCas [4, 5]. This evidence concerns the gene TMPRSS2 and posterior cortical atrophy.